Use of Glycated Hemoglobin and Waist Circumference for Diabetic Screening in Women With a History of Gestational Diabetes

Journal of Obstetrics and Gynaecology Canada

Volumn 35, Issue 9, 2013, Pages 810-815

  Gingras, Véronique ^a   Tchernof, André ^a   Weisnagel, S John ^a   Robitaille, Julie ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

A1C; Gestational diabetes; Testing; Waist circumference

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; BLOOD; DIABETES MELLITUS, TYPE 2; PREDIABETIC STATE; PREGNANCY; A1C; TESTING;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PREDIABETIC STATE; PREGNANCY; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE;

A1C; GESTATIONAL DIABETES; TESTING; WAIST CIRCUMFERENCE;

EID: 84893451890     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30837-9     Document Type: Article

References (30)

1. American Diabetes Association Standards of medical care in diabetes-2013. Diabetes Care 2013, 36(Suppl 1):S11-S66.
2. Feig D.S., Zinman B., Wang X., Hux J.E. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 2008, 179:229-234.
3. Bellamy L., Casas J.P., Hingorani A.D., Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773-1779.
4. Akinci B., Celtik A., Yener S., Yesil S. Prediction of developing metabolic syndrome after gestational diabetes mellitus. Fertil Steril 2010, 93:1248-1254.
5. Retnakaran R., Qi Y., Connelly P.W., Sermer M., Zinman B., Hanley A.J. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010, 95:670-677.
6. Canadian Diabetes Association Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008, 32(Suppl 1):S168-S180.
7. Smirnakis K.V., Chasan-Taber L., Wolf M., Markenson G., Ecker J.L., Thadhani R. Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol 2005, 106:1297-1303.
8. Ferrara A., Peng T., Kim C. Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2009, 32:269-274.
9. Shah B.R., Lipscombe L.L., Feig D.S., Lowe J.M. Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study. BJOG 2011, 118:1484-1490.
10. Bennett W.L., Bolen S., Wilson L.M., Bass E.B., Nicholson W.K. Performance characteristics of postpartum screening tests for type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review. J Womens Health 2009, 18:979-987.
11. Kwong S., Mitchell R.S., Senior P.A., Chik C.L. Postpartum diabetes screening adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care 2009, 32:2242-2244.
12. Kim C., Herman W.H., Cheung N.W., Gunderson E.P., Richardson C. Comparison of hemoglobin A(1c) with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus. Diabetes Care 2011, 34:1949-1951.
13. Picón M.J., Murri M., Muñoz A., Fernández-García J.C., Gomez-Huelgas R., Tinahones F.J. Hemoglobin A1c Versus oral glucose tolerance test in postpartum diabetes screening. Diabetes Care 2012, 35:1648-1653.
14. de Guadiana García, Romualdo L., González Morales M., Albaladejo Otón M.D., Martín García E., Martín-Ondarza González Mdel C., Nuevo García J., et al. The value of hemoglobin A1c for diagnosis of diabetes mellitus and other changes in carbohydrate metabolism in women with recent gestational diabetes mellitus. Endocrinol Nutr 2012, 59:362-366.
15. Retnakaran R., Qi Y., Sermer M., Connelly P.W., Hanley A.J., Zinman B. The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancy. Nutr Metab Cardiovasc Dis 2011, 21:706-712.
16. Stuebe A.M., Mantzoros C., Kleinman K., Gillman M.W., Rifas-Shiman S., Seely E.W., et al. Gestational glucose tolerance and maternal metabolic profile at 3 years postpartum. Obstet Gynecol 2011, 118:1065-1073.
17. Wahrenberg H., Hertel K., Leijonhufvud B.M., Persson L.G., Toft E., Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ 2005, 330:1363-1364.
18. Janssen I., Katzmarzyk P.T., Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002, 162(18):2074-2079.
19. Pouliot M.C., Després J.P., Lemieux S., Moorjani S., Bouchard C., Tremblay A., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994, 73:460-468.
20. Gingras V., Paradis A.M., Tchernof A., Weisnagel S.J., Robitaille J. Relationship between the adoption of preventive practices and the metabolic profile of women with prior gestational diabetes mellitus. Appl Physiol Nut Metab 2012, 37(6):1232-1238.
21. Lohman T., Roche A., Martorel R. Standardization of anthropometric measurements: The Airlie (VA) Consensus Conference. Champaign, Ill: Human Kinetics Publishers 1988, 1988:39-80.
22. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
23. Richterich R., Dauwalder H. Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method. Schweiz Med Wochenschr 1971, 101:615-618.
24. Desbuquois B., Aurbach G.D. Use of polyethylene glycol to separate free antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 1971, 37:732-738.
25. Megia A., Näf S., Herranz L., Serrat N., Yañez R.E., Simón I., et al. The usefulness of HbA1c in postpartum reclassification of gestational diabetes. BJOG 2012, 119:891-894.
26. The International Expert Committee International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
27. Goldenberg R.M., Cheng A.Y.Y., Punthakee Z., Clement M. Use of glycated hemoglobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults. Can J Diabetes 2011, 35:247-249.
28. Herman W.H., Ma Y., Uwaifo G., Haffner S., Kahn S.E., Horton E.S., et al. Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007, 30:2756-2758.
29. Ramachandran A., Riddle M., Kabali C., Gerstein H. ORIGIN investigators. Relationship between A1C and fasting plasma glucose in dysglycemia or type 2 diabetes: an analysis of baseline data from the ORIGIN trial. Diabetes Care 2012, 35:749-753.
30. Alberti K., Zimmet P., Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide. Lancet 2005, 366:1059-1062.